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Figure 1. 
CLINICAL HISTORY
In 2002, a 55-year-old male patient was referred for neu-
rosurgical consultation after two episodes of speech arrest 
and a newly diagnosed mass lesion in the superior left 
temporal gyrus extending to the insula. The patient under-
went a pterional craniotomy with partial resection of the 
tumor. The histopathological examination revealed an oli-
godendroglioma (WHO II). A follow-up MRI in 2007 dem-
onstrated significant growth of the residual tumor mass 
(Figure 1A–D). Accordingly, the patient was started on 
standard therapy with temozolomide. In 2011, MRI showed 
tumor progression, which prompted additional tumor resec-
tion. The histological examination revealed features of ana-
plastic oligodendroglioma with codeletion of 1p/19q. 
Postoperative treatment included adjuvant radiotherapy 
(32  ×  1.8  Gy  =  57.6  Gy). In June 2015, follow-up 
MRI revealed a local recurrence consistent with tumor pro-
gression. Meanwhile, the patient had undergone surgical 
resection of adenocarcinoma of the colon, diagnosed in 
2015, and treated with adjuvant chemotherapy (FOLFOX4). 
The decision was made to suspend further treatment and 
to follow the patient with MRI. Of note, the regression of 
the tumor mass was observed in the parahippocampal gyrus.
In September 2016, 14 years after the initial diagnosis 
of oligodendroglioma, follow-up MRI of the liver was per-
formed according to the staging protocol for metastatic 
adenocarcinoma. MRI of the abdomen revealed the incidental 
finding of an intradural tumor attached to the conus 
medullaris. MRI of the lumbar spine showed a circumscribed, 
intradural and extramedullary tumor (11  ×  13  ×  24  mm). 
The tumor occupied the spinal canal between Th12-L1, 
shifting the conus to the left, as well as infiltrating the 
fibers of the cauda equina (Figure 1E–H). The clinical 
examination revealed mild paresis of the right leg, in par-
ticular, the right hip and foot flexors (M4/5).
Laminoplasty was performed at Th12-L1 and the intradural 
and intramedullary lesion were resected. The postoperative 
course was uneventful and the patient did not show any 
new deficits after surgery (Figure 1I–L, postoperative MRI). 
The histological diagnosis is discussed below in detail.
MICROSCOPIC PATHOLOGY
Multiple tissue fragments measuring 8  ×  8  ×  1  mm in 
total were submitted for the histological examination. The 
microscopic examination revealed a neoplasm composed of 
closely packed and relatively uniform round cells with peri-
nuclear halos. Frequent mitoses were observed, which were 
accompanied by microvascular proliferation and pseudo-
palisading necrosis (Figure 1M–O). Scattered calcospherites 
were present. The nuclei and cytoplasm of the tumor cells 
were immunoreactive for the IDH1R132H-mutation. ATRX 
immunohistochemistry showed retained nuclear expression. 
The tumor cells were epithelial membrane antigen (EMA) 
negative and glial fibrillary acidic protein (GFAP) positive 
(Figure 1P–Q). The MIB1-proliferation index was high, 
reaching 50% (Figure 1R). What is your diagnosis?
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DIAGNOSIS
Drop metastasis of an anaplastic oligodendroglioma.
DISCUSSION
Malignant progression in patients with oligodendroglioma 
is inevitable (3). However, the prognosis is generally more 
favorable than astrocytomas of the corresponding grade. 
Oligodendrogliomas, which usually arise in the cerebral 
hemispheres, primarily recur locally, typically within the 
resection margins or treatment fields (2). Nevertheless, spinal 
drop metastasis from oligodendroglioma is a rare finding 
with fewer than dozen cases since first reported in 1971 
(1) In the present case, 14 years elapsed after the initial 
diagnosis of oligodendroglioma. During a staging MRI for 
metastatic adenocarcinoma, an intradural tumor attached 
to the conus medullaris was detected, which was considered 
compatible with schwannoma or ependymoma. Surprisingly, 
the histopathological examination revealed an anaplastic 
oligodendroglioma. Of note, additional tumor resection of 
the intracranial oligodendroglioma was performed four 
months after the resection of the spinal drop metastasis. 
The histological examination revealed features of anaplastic 
oligodendroglioma with codeletion of 1p/19q.
While primary brain tumors such as glioblastoma, fol-
lowed by primitive neuroectodermal tumors (PNET) and 
ependymomas are more likely to metastasize to the spinal 
canal, metastatic spread of oligodendroglioma is exceed-
ingly rare (1). The mechanism underlying the metastatic 
spread of oligodendroglioma is controversial, with possible 
pathways including tumor dissemination via the 
cerebrospinal fluid pathways or even hematogenous spread. 
In cases of leptomeningeal disease or scalp involvement 
associated with multiple craniotomies, spread along lym-
phatic channels to regional lymph nodes followed by distal 
metastases is discussed (2). Tumor dissemination via the 
cerebrospinal fluid, reported in up to 14% of patients with 
oligodendroglioma, is thought to arise after surgical inter-
vention with breaching the pia mater and ependymal lining 
(4). Isolated intramedullary metastases are suggested to 
occur from hematogenous dissemination.
The short survival in patients with anaplastic oligoden-
droglioma combined with the relatively slow growth rate 
has been considered as an explanation for the rare occur-
rence of metastasis (1). Thus, in the future, the incidence 
of patients with spinal drop metastasis of oligodendroglioma 
is likely to increase due to improved therapies and longer 
survival of patients.
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